EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialists

Marie Madeleine Dolmans, Matteo Lambertini, Kirsten Tryde Macklon, Teresa Almeida Santos, Ana Ruiz-Casado, Andrea Borini, Virginie Bordes, Lucy Frith, Ellen Van Moer, Ariane Germeyer

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

In recent years, following the improved prognosis of patients with cancer, interest and attention has grown around fertility issues in these patients. International guidelines on fertility preservation in patients with cancer recommend that physicians discuss with all patients of reproductive age (or their parents/guardians, if children) the risk of infertility arising from their cancer or its treatment. Oncofertility counselling is recommended at the earliest opportunity and prior to cancer treatment, to help patients make informed decisions on pursuing fertility preservation. Currently, however, such discussions are not being routinely held. In June 2017, an esteemed group of European oncofertility experts met to discuss current unfulfilled needs in oncofertility for female cancer patients. This expert group has produced here a number of key recommendations in order to guide oncologists, haematologists, and other involved professionals with oncofertility discussions and appropriate referrals for further fertility preservation counselling and follow-up.

Original languageEnglish
Pages (from-to)233-240
Number of pages8
JournalCritical Reviews in Oncology/Hematology
Volume138
DOIs
Publication statusPublished - Jun 1 2019
Externally publishedYes

Fingerprint

Fertility Preservation
Fertility
Neoplasms
Counseling
Infertility
Oncologists
Referral and Consultation
Parents
Guidelines
Physicians
Therapeutics

Keywords

  • Expert recommendations
  • Female cancer patients
  • Fertility preservation
  • Haematologists
  • Oncofertility
  • Oncologists

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

EUropean REcommendations for female FERtility preservation (EU-REFER) : A joint collaboration between oncologists and fertility specialists. / Dolmans, Marie Madeleine; Lambertini, Matteo; Macklon, Kirsten Tryde; Almeida Santos, Teresa; Ruiz-Casado, Ana; Borini, Andrea; Bordes, Virginie; Frith, Lucy; Van Moer, Ellen; Germeyer, Ariane.

In: Critical Reviews in Oncology/Hematology, Vol. 138, 01.06.2019, p. 233-240.

Research output: Contribution to journalReview article

Dolmans, MM, Lambertini, M, Macklon, KT, Almeida Santos, T, Ruiz-Casado, A, Borini, A, Bordes, V, Frith, L, Van Moer, E & Germeyer, A 2019, 'EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialists', Critical Reviews in Oncology/Hematology, vol. 138, pp. 233-240. https://doi.org/10.1016/j.critrevonc.2019.03.010
Dolmans, Marie Madeleine ; Lambertini, Matteo ; Macklon, Kirsten Tryde ; Almeida Santos, Teresa ; Ruiz-Casado, Ana ; Borini, Andrea ; Bordes, Virginie ; Frith, Lucy ; Van Moer, Ellen ; Germeyer, Ariane. / EUropean REcommendations for female FERtility preservation (EU-REFER) : A joint collaboration between oncologists and fertility specialists. In: Critical Reviews in Oncology/Hematology. 2019 ; Vol. 138. pp. 233-240.
@article{783c509c91f34508b140e176d3190d5b,
title = "EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialists",
abstract = "In recent years, following the improved prognosis of patients with cancer, interest and attention has grown around fertility issues in these patients. International guidelines on fertility preservation in patients with cancer recommend that physicians discuss with all patients of reproductive age (or their parents/guardians, if children) the risk of infertility arising from their cancer or its treatment. Oncofertility counselling is recommended at the earliest opportunity and prior to cancer treatment, to help patients make informed decisions on pursuing fertility preservation. Currently, however, such discussions are not being routinely held. In June 2017, an esteemed group of European oncofertility experts met to discuss current unfulfilled needs in oncofertility for female cancer patients. This expert group has produced here a number of key recommendations in order to guide oncologists, haematologists, and other involved professionals with oncofertility discussions and appropriate referrals for further fertility preservation counselling and follow-up.",
keywords = "Expert recommendations, Female cancer patients, Fertility preservation, Haematologists, Oncofertility, Oncologists",
author = "Dolmans, {Marie Madeleine} and Matteo Lambertini and Macklon, {Kirsten Tryde} and {Almeida Santos}, Teresa and Ana Ruiz-Casado and Andrea Borini and Virginie Bordes and Lucy Frith and {Van Moer}, Ellen and Ariane Germeyer",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.critrevonc.2019.03.010",
language = "English",
volume = "138",
pages = "233--240",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - EUropean REcommendations for female FERtility preservation (EU-REFER)

T2 - A joint collaboration between oncologists and fertility specialists

AU - Dolmans, Marie Madeleine

AU - Lambertini, Matteo

AU - Macklon, Kirsten Tryde

AU - Almeida Santos, Teresa

AU - Ruiz-Casado, Ana

AU - Borini, Andrea

AU - Bordes, Virginie

AU - Frith, Lucy

AU - Van Moer, Ellen

AU - Germeyer, Ariane

PY - 2019/6/1

Y1 - 2019/6/1

N2 - In recent years, following the improved prognosis of patients with cancer, interest and attention has grown around fertility issues in these patients. International guidelines on fertility preservation in patients with cancer recommend that physicians discuss with all patients of reproductive age (or their parents/guardians, if children) the risk of infertility arising from their cancer or its treatment. Oncofertility counselling is recommended at the earliest opportunity and prior to cancer treatment, to help patients make informed decisions on pursuing fertility preservation. Currently, however, such discussions are not being routinely held. In June 2017, an esteemed group of European oncofertility experts met to discuss current unfulfilled needs in oncofertility for female cancer patients. This expert group has produced here a number of key recommendations in order to guide oncologists, haematologists, and other involved professionals with oncofertility discussions and appropriate referrals for further fertility preservation counselling and follow-up.

AB - In recent years, following the improved prognosis of patients with cancer, interest and attention has grown around fertility issues in these patients. International guidelines on fertility preservation in patients with cancer recommend that physicians discuss with all patients of reproductive age (or their parents/guardians, if children) the risk of infertility arising from their cancer or its treatment. Oncofertility counselling is recommended at the earliest opportunity and prior to cancer treatment, to help patients make informed decisions on pursuing fertility preservation. Currently, however, such discussions are not being routinely held. In June 2017, an esteemed group of European oncofertility experts met to discuss current unfulfilled needs in oncofertility for female cancer patients. This expert group has produced here a number of key recommendations in order to guide oncologists, haematologists, and other involved professionals with oncofertility discussions and appropriate referrals for further fertility preservation counselling and follow-up.

KW - Expert recommendations

KW - Female cancer patients

KW - Fertility preservation

KW - Haematologists

KW - Oncofertility

KW - Oncologists

UR - http://www.scopus.com/inward/record.url?scp=85065496993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065496993&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2019.03.010

DO - 10.1016/j.critrevonc.2019.03.010

M3 - Review article

AN - SCOPUS:85065496993

VL - 138

SP - 233

EP - 240

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

ER -